Ulcerative colitis flair induced by mesalamine suppositories hypersensitivity

被引:6
|
作者
Ding, Hao [1 ]
Liu, Xiao-Chang [1 ]
Mei, Qiao [1 ]
Xu, Jian-Ming [1 ]
Hu, Xiang-Yang [2 ]
Hu, Jing [1 ]
机构
[1] Anhui Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Hefei 230022, Anhui, Peoples R China
[2] Anhui Med Univ, Affiliated Hosp 1, Dept Pathol, Hefei 230022, Anhui, Peoples R China
关键词
Mesalamine suppositories; Hypersensitivity; Ulcerative colitis; Surgery; Sulfasalazine; 5-AMINOSALICYLIC ACID; MESALAZINE; EXACERBATION; TRIAL;
D O I
10.3748/wjg.v20.i13.3716
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mesalamine suppositories have been used widely for the treatment of distal ulcerative colitis and considered to be safer than systemic administration for its limited systemic absorption. However, previous studies have shown that mesalamine suppository occasionally causes severe hypersensitivity reactions including fever, rashes, colitis exacerbation and acute eosinophilic pneumonia. Here we present a 25-year-old woman with ulcerative colitis with bloody diarrhea accompanied by abdominal pain and fever which were aggravated after introduction of mesalamine suppositories. In light of symptom exacerbation of ulcerative colitis, increased inflammatory injury of colon mucosa shown by colonoscopy and elevated peripheral eosinophil count after mesalamine suppositories administration, and the Naranjo algorithm score of 10, the possibility of hypersensitivity reaction to mesalamine suppositories should be considered, warning us to be aware of this potential reaction after administration of mesalamine formulations even if it is the suppositories. (C) 2014 Baishideng Publishing Group Co., Limited. All rights reserved.
引用
收藏
页码:3716 / 3718
页数:3
相关论文
共 50 条
  • [31] Multi-Matrix System (MMX®) mesalamine for the treatment of mild-to-moderate ulcerative colitis
    Horst, Sara N.
    Kane, Sunanda
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (15) : 2225 - 2232
  • [32] Efficacy of the pH-dependent release formulation of mesalamine in patients with ulcerative colitis
    Tanaka, Hiroki
    Yamashita, Masaki
    Nasuno, Masanao
    Ishii, Manabu
    Motoya, Satoshi
    Imamura, Akimichi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 133 - 134
  • [33] Preparation and evaluation of mesalamine collagen in situ rectal gel: A novel therapeutic approach for treating ulcerative colitis
    Ramadass, Satiesh Kumar
    Perumal, Sathiamurthi
    Jabaris, Sugin Lal
    Madhan, Balaraman
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 48 (1-2) : 104 - 110
  • [34] Mesalamine Dose Escalation Reduces Fecal Calprotectin in Patients With Quiescent Ulcerative Colitis
    Osterman, Mark T.
    Aberra, Faten N.
    Cross, Raymond
    Liakos, Steven
    McCabe, Robert
    Shafran, Ira
    Wolf, Douglas
    Hardi, Robert
    Nessel, Lisa
    Brensinger, Colleen
    Gilroy, Erin
    Lewis, James D.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (11) : 1887 - U369
  • [35] Inducing and Maintaining Remission in Ulcerative Colitis Role of High-dose, Extended-release Mesalamine
    Kao, James
    Kwok, Karl
    Das, Kiron M.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2010, 44 (08) : 531 - 535
  • [36] Impact of MMX® Mesalamine on Improvement and Maintenance of Health-Related Quality of Life in Patients with Ulcerative Colitis
    Hodgkins, Paul
    Yen, Linnette
    Yarlas, Aaron
    Karlstadt, Robyn
    Solomon, Dory
    Kane, Sunanda
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (02) : 386 - 396
  • [37] Ulcerative colitis possibly due to hypersensitivity to wheat and egg
    Vautrin, DAM
    Sainte-Laudy, J
    Kanny, G
    ALLERGY, 2001, 56 (05) : 458 - 459
  • [38] Once-Daily MMX® Mesalamine for Endoscopic Maintenance of Remission of Ulcerative Colitis
    D'Haens, Geert
    Sandborn, William J.
    Barrett, Karen
    Hodgson, Ian
    Streck, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (07): : 1064 - 1077
  • [39] MESALAZINE INDUCED EXACERBATION OF ULCERATIVE-COLITIS
    KAPUR, KC
    WILLIAMS, GT
    ALLISON, MC
    GUT, 1995, 37 (06) : 838 - 839
  • [40] Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission
    Gary R. Lichtenstein
    Glenn L. Gordon
    Salam Zakko
    Uma Murthy
    Shahriar Sedghi
    Ron Pruitt
    Andrew C. Barrett
    Enoch Bortey
    Craig Paterson
    William P. Forbes
    Digestive Diseases and Sciences, 2016, 61 : 221 - 229